[Federal Register Volume 63, Number 27 (Tuesday, February 10, 1998)] [Notices] [Pages 6761-6762] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-3295] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committees; Renewals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) announces the renewal of certain FDA advisory [[Page 6762]] committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed below for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed below. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92-463 (5 U.S.C. app. 2)). DATES: Authority for these committees will expire on the dates indicated below unless the Commissioner formally determines that renewal is in the public interest. ------------------------------------------------------------------------ Name of committee Date of expiration ------------------------------------------------------------------------ Antiviral Drugs Advisory Committee February 15, 1999 National Mammography Quality Assurance July 6, 1999 Advisory Committee Nonprescription Drugs Advisory Committee August 27, 1999 Advisory Committee on Special Studies December 2, 1999 Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants Food Advisory Committee December 18, 1999 Vaccines and Related Biological Products December 31, 1999 Advisory Committee ------------------------------------------------------------------------ FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4820. Dated: February 4, 1998. Michael A. Friedman, Lead Deputy Commissioner for the Food and Drug Administration. [FR Doc. 98-3295 Filed 2-9-98; 8:45 am] BILLING CODE 4160-01-F